The field of longevity research, which aims to increase not just lifespan but also healthspan, has received significant investment from tech billionaires and pharmaceutical companies in recent years. While governments have also contributed to this area of study, private funding has far outstripped public funding, leading to debates about the role of governments in supporting fundamental science and the potential consequences of transferring early stage research to private institutions. Essentia...
